10-Q: Planet 13 Reports Steep Losses, Exits California Market

Planet 13 Holdings Inc. reported a significant net loss of $59.3 million for the nine months ended September 30, 2025, alongside declining revenues and gross profit margins, while announcing a strategic exit from its California operations.

Summary

• Net revenue for the nine months ended September 30, 2025, decreased by 9.3% to $78.16 million, down from $86.12 million in the prior year period.
• Gross profit for the nine months ended September 30, 2025, fell by 33.5% to $28.62 million, compared to $43.02 million in the same period last year.
• Gross profit margin significantly declined to 36.6% for the nine months ended September 30, 2025, from 49.9% in the prior year.
• The company incurred a substantial net loss of $59.30 million for the nine months ended September 30, 2025, a 177.7% increase from the $21.36 million net loss in the comparable 2024 period.
• An impairment loss of $29.84 million was recognized for the nine months ended September 30, 2025, primarily related to cultivation assets in California and Nevada due to market price compression.
• Cash on hand decreased to $17.18 million as of September 30, 2025, from $23.38 million at December 31, 2024.
• Total liabilities increased to $103.91 million as of September 30, 2025, from $94.02 million at December 31, 2024, while total shareholders' equity decreased to $54.58 million from $112.71 million.
• The company fully drew on a $9.75 million cash-secured revolving line of credit to pay off other notes and fund construction projects.
• Planet 13 announced plans to discontinue operations at its Orange County, California dispensary and Coalinga, California cultivation facility, expecting to divest all California operations by early Q1 2026.

Sentiment

Score: 2

Explanation: The company reported substantial net losses, significant revenue and gross profit declines, and large impairment charges. The strategic exit from California, while aimed at future profitability, highlights current underperformance. The 'going concern' warning and reliance on a revolving credit line further underscore severe financial challenges, leading to a very negative sentiment.

Positives

• Working capital increased to $18,564,637 as of September 30, 2025, from $15,564,382 as of September 30, 2024.
• Successfully paid off a $2,947,632 promissory note to Lafayette State Bank on February 11, 2025, and a $5,000,000 promissory note to former VidaCann shareholders on April 1, 2025.
• Recovered $2.1 million in funds and real estate valued at approximately $5.0 million (net $4.6 million) in a legal settlement related to the El Capitan matter, though the property was later sold at a loss.
• Continuing capital outlays to utilize the Florida MMTC license, expanding the retail store network to 33 dispensaries and nearing completion on a new butane hash oil lab facility by late Q4 2025.

Negatives

• Net revenue decreased by 27.6% for the three months and 9.3% for the nine months ended September 30, 2025, primarily due to price compression and increased competition in Florida.
• Gross profit margin significantly declined to 21.3% for the three months and 36.6% for the nine months ended September 30, 2025, impacted by price compression and overcapacity at cultivation/production facilities leading to aged inventory.
• Reported a net loss of $43.96 million for the three months and $59.30 million for the nine months ended September 30, 2025, substantially worse than prior periods.
• Incurred a $29.84 million impairment loss on cultivation assets in California and Nevada due to declining market prices for flower.
• Cash flows used in operating activities were $10.57 million for the nine months ended September 30, 2025, a significant shift from cash provided by operating activities of $6.64 million in the prior year.
• Total assets decreased by approximately $48.24 million from December 31, 2024, to September 30, 2025.
• Total shareholders' equity decreased by approximately $58.13 million from December 31, 2024, to September 30, 2025.
• The company is discontinuing operations in California, indicating underperformance in that market.

Risks

• Actual financial position and results of operations may differ from management's expectations.
• Lack of business diversification, with operations concentrated in specific states.
• Increasing competition from larger, better-financed companies and new market entrants.
• Negative public opinion and perception of the cannabis industry.
• Significant costs and obligations associated with operations and expansion.
• Reliance on limited jurisdictions (Nevada, California, Florida, Illinois) exposes the company to regional economic downturns.
• Challenges in accessing capital due to the federal illegality of cannabis.
• Risks inherent in an agricultural business, including crop failures and disease.
• Risks related to energy costs impacting cultivation and production.
• Breaches of security at facilities could lead to losses.
• Reliance on suppliers for various operational needs.
• Concentrated voting control of the Company by certain shareholders.
• Risks associated with being a holding company.
• Service providers may withdraw or suspend services due to federal prosecution threats.
• Potential infringement of proprietary intellectual property by third parties.
• General litigation risks, including those related to intellectual property.
• Risks associated with cannabis products manufactured for human consumption, including potential product recalls.
• Inability to attract and retain key personnel.
• Challenges in obtaining and retaining relevant cannabis licenses.
• Risks related to integrating acquired businesses, such as VidaCann.
• Difficulty in accurately quantifying the target market.
• Risks related to industry growth and consolidation.
• Potential for fraudulent activity by employees, contractors, and consultants.
• Cyber-security risks to data and systems.
• Conflicts of interest involving management and related parties.
• Reputational damage from various factors.
• Risks associated with leased premises.
• Impacts from epidemics and pandemics.
• Uncertainty in the U.S. regulatory landscape and enforcement related to cannabis, including political risks.
• Heightened scrutiny by Canadian regulatory authorities.
• Risks related to capital raising due to heightened regulatory scrutiny.
• Significant tax liabilities under Section 280E of the Internal Revenue Code, prohibiting deductions for cannabis businesses.
• Risks related to U.S. state and local laws and regulations.
• Difficulty accessing traditional banking and credit card payment processors due to federal illegality.
• Potential for asset forfeiture by law enforcement due to federal illegality of cannabis.
• Credit risk from third parties failing to discharge obligations.
• Interest rate risk from fluctuating market interest rates.
• Price risk affecting the trading price of the company's shares and ability to raise funds.
• Liquidity risk in meeting liabilities when due, with no assurance of continued access to significant equity financing.
• Currency rate risk, though currently deemed insignificant.

Future Outlook

The company plans to focus its resources on its highest performing markets, Nevada and Florida, and discontinue California operations by early Q1 2026 to position for long-term growth and profitability. It is continuing capital outlays for its Florida MMTC license, expanding its retail network, and expects to complete a new butane hash oil lab facility by late Q4 2025. In Illinois, the company plans to introduce its exclusive product line through licensing agreements for retail and wholesale in 2026. Management believes it has adequate liquidity to fund planned capital expenditures and operations for the next 12 months, including Florida expansion, and expects to use proceeds from the sale of its Coalinga, California cultivation facility for this purpose.

Management Comments

• The decrease in net revenue was primarily driven by price compression in all markets and an increase in new dispensaries in the Florida market.
• A decline in tourism in Las Vegas, combined with an overall reduction in the disposable income of our customers, negatively impacted customer visits to the Planet 13 Las Vegas Superstore and other retail locations.
• The flower category suffered from intense price compression and oversupply in the market, negatively impacting both retail and wholesale revenue.
• The decrease in gross profit margin was a result of price compression in retail and wholesale markets, particularly in the flower category, and issues related to overcapacity at cultivation and production facilities leading to aged inventory.
• The company increased its reserve for slow moving inventory by $3,500,000 and has implemented additional strategies to help prevent excess inventory build and reduce production costs.
• Excluding the impact of inventory related charges and California wholesale revenue at or below cost to produce, the company estimates gross margin at approximately 45% for both the three and nine months ended September 30, 2025.
• The increase in G&A expenses was a result of the addition of VidaCann operations and an increase in share-based compensation, partially mitigated by focused cost cutting initiatives.
• The decision to discontinue California operations reflects the company's strategy to focus resources on its highest performing markets and to position the company for long-term growth and profitability.
• The closure of the Coalinga, California cultivation facility was necessary to improve overall profitability and cash flow and to focus on core businesses in Nevada and Florida.

Industry Context

The cannabis industry continues to face significant challenges, including intense price compression and oversupply, particularly in the flower category, across various markets like Nevada and California. This competitive environment, coupled with an increase in new dispensaries in markets like Florida and a decline in consumer disposable income, is impacting revenue and profitability for operators. The illicit market and intoxicating hemp products also pose competitive threats. The federal illegality of cannabis continues to create banking and tax burdens (e.g., Section 280E) for state-legal businesses, hindering their financial health and access to traditional capital.

Comparison to Industry Standards

• The significant decline in gross profit margin from 49.9% to 36.6% year-over-year for the nine months ended September 30, 2025, indicates underperformance compared to industry leaders who often maintain higher margins through efficient operations and strong brand pricing power.
• The substantial net loss of $59.30 million for the nine months ended September 30, 2025, contrasts sharply with more established or profitable multi-state operators (MSOs) that have achieved or are nearing profitability, demonstrating Planet 13's struggle in the current market.
• The impairment charges of $29.84 million on cultivation assets suggest that the company's asset valuations and operational efficiency in California and Nevada have fallen below market expectations and industry benchmarks for asset productivity.
• The strategic exit from California operations, a major cannabis market, indicates an inability to compete effectively or achieve desired profitability in that region, unlike some competitors who have successfully scaled operations there.
• The reliance on a revolving line of credit for operational needs and debt repayment, despite having assets for sale, suggests a tighter liquidity position compared to peers with stronger cash generation or access to more diverse, less restrictive financing.

Corporate Governance

Legal Proceedings

• The company is not presently a party to any legal proceedings that, in management's opinion, would individually or taken together have a material adverse effect on its business, operating results, financial condition, or cash flows as of September 30, 2025.
• Litigation, regardless of outcome, can have an adverse impact due to defense and settlement costs, diversion of management resources, negative publicity, and reputational harm.

Related Party Transactions

• The company has a long-term lease agreement with Loop's Nursery (primarily owned by David Loop, a board member) for its primary cultivation facility in Florida, with payments of $2,618,755 for the nine months ended September 30, 2025.
• Acquired related party notes payable to David Loop and Mark Ascik (VidaCann former managers) as part of the VidaCann acquisition, with interest payments totaling $84,452 for the nine months ended September 30, 2025.
• Entered into a 30-month lease agreement with PRMN Investments Ltd (primarily owned by Robert Groesbeck, Co-CEO) for a Florida apartment unit, with payments of $41,330 for the nine months ended September 30, 2025.
• Entered into a three-month consulting agreement with Off the House, LLC (owned by the stepson of Robert Groesbeck, Co-CEO) effective September 19, 2025, with $18,250 due as of September 30, 2025.

Stakeholder Impact

• **Shareholders**: Significant net losses and declining equity will negatively impact shareholder value. The strategic divestment of California assets may be seen as a necessary step for long-term stability but reflects past underperformance. Potential future equity raises could lead to dilution.
• **Employees**: Discontinuation of California operations will result in job losses at the Orange County dispensary and Coalinga cultivation facility. The focus on Nevada and Florida may create new opportunities in those regions.
• **Customers**: The exit from California will mean a loss of Planet 13 retail presence for customers in that state. Expansion in Florida aims to serve more medical cannabis patients.
• **Creditors**: The company's increased liabilities and reliance on a revolving line of credit, despite debt repayments, indicate a higher risk profile. The 'going concern' warning could raise concerns for lenders.
• **Suppliers**: Changes in operational footprint and production strategies (e.g., reducing excess inventory) may impact relationships and volumes with suppliers, particularly in California.

Next Steps

• Complete the sale of the Orange County, California dispensary, awaiting regulatory approvals for transfer of the retail license (expected within approximately three to four months of October 29, 2025).
• Wind-down operations and sell through existing inventory at the Coalinga, California cultivation facility through the remainder of 2025.
• Focus resources on highest performing markets: Nevada and Florida.
• Continue capital outlays to utilize the Florida MMTC license, including tenant improvements and regulatory inspection for an additional dispensing location in Sarasota, Florida.
• Complete construction of a new butane hash oil lab facility in Florida to enhance the product portfolio (expected in late fourth quarter of 2025).
• Introduce exclusive product lines through licensing agreements for sale at its retail store and wholesale throughout Illinois in 2026.

Key Dates

Recommendation

The filing reveals a company in significant financial distress, marked by a substantial increase in net losses, sharp declines in revenue and gross profit margins, and a large impairment charge on assets. The strategic decision to exit the California market, while potentially prudent for future focus, underscores past operational failures in a key market. The 'going concern' disclosure, coupled with negative cash flow from operations and increased liabilities, indicates severe liquidity challenges. While some debt has been repaid, it was largely funded by drawing down a revolving credit line. These factors collectively point to a highly unfavorable investment outlook, warranting a strong sell recommendation for seasoned investors.

Keywords

Cannabis, Marijuana, SEC Filing, 10-Q, Quarterly Report, Financial Results, Net Loss, Revenue Decline, Gross Profit Margin, Impairment Loss, California Exit, Florida Expansion, Nevada Operations, Illinois Dispensary, VidaCann, Cannabis Industry, Multi-state Operator, MSO, Cannabis Regulation, Section 280E, Liquidity, Capital Resources, Stock, Investment